Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility
When different drug products are produced in shared facilities, the potential for cross-contamination is always a concern that needs to be addressed.
Drug products provide a benefit to the intended patient. However, as a cross-contaminant, they can pose a risk.
This is especially true when manufacturing oncology drugs, as many of them are highly potent substances with cytotoxic or genotoxic effects, while others are not.
Download to find out more.